Masataka Wada

Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study

Ryosuke Tarumi, Sakiko Tsugawa, Yoshihiro Noda et al. · Neuropsychopharmacology · 2019 · 61 citations · Full text

Severe Treatment-resistant Schizophrenia, Psychiatry, Neurophysiology +11

Effect of Education on Alzheimer’s Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer’s Disease: A Cross-Sectional Study

Masataka Wada, Yoshihiro Noda, Shunichiro Shinagawa et al. · Journal of Alzheimer s Disease · 2018 · 45 citations

Polygenic risk scores for major psychiatric and neurodevelopmental disorders contribute to sleep disturbance in childhood: Adolescent Brain Cognitive Development (ABCD) Study

Kazutaka Ohi, Ryo Ochi, Yoshihiro Noda et al. · Translational Psychiatry · 2021 · 40 citations · Full text

The key role of calreticulin in immunomodulation induced by chemotherapeutic agents

Yoshiyuki Yamamura, Takahiro Tsuchikawa, Kengo Miyauchi et al. · International Journal of Clinical Oncology · 2014 · 35 citations

Chemotherapeutic Agents, Signal Transduction, Key Role +10

White matter microstructural organizations in patients with severe treatment-resistant schizophrenia: A diffusion tensor imaging study

Ryo Ochi, Yoshihiro Noda, Shohei Tsuchimoto et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2020 · 29 citations

Neuroimaging Biomarkers, Severe Treatment-resistant Schizophrenia, Psychiatry +9